Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
E Diamanti‐Kandarakis, I Katsikis, C Piperi… - Clinical …, 2008 - Wiley Online Library
Background Nonenzymatic advanced glycation and oxidation end‐products, advanced
glycation end‐products (AGEs), impart a potent impact on vessels and other tissues in …
glycation end‐products (AGEs), impart a potent impact on vessels and other tissues in …
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome
BACKGROUND Women with polycystic ovary syndrome (PCOS) have been reported to
have subclinical cardiovascular disease (CVD) and increased abdominal fat. The aim of this …
have subclinical cardiovascular disease (CVD) and increased abdominal fat. The aim of this …
Statins in the treatment of polycystic ovary syndrome
PH Kodaman, AJ Duleba - Seminars in reproductive medicine, 2008 - thieme-connect.com
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting
reproductive-aged women. The hyperandrogenemia associated with the syndrome is a …
reproductive-aged women. The hyperandrogenemia associated with the syndrome is a …
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS)
F Giallauria, S Palomba, L Maresca… - Clinical …, 2008 - Wiley Online Library
Background Polycystic ovary syndrome (PCOS) is a common female reproductive‐age
endocrine disease predominantly characterized by chronic anovulation, hyperandrogenism …
endocrine disease predominantly characterized by chronic anovulation, hyperandrogenism …
[PDF][PDF] Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review.
Polycystic ovary syndrome (PCOS) is a common disorder associated with chronic
anovulatory infertility and hyperandrogenaemia with the clinical manifestation of …
anovulatory infertility and hyperandrogenaemia with the clinical manifestation of …
Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone …
D Glintborg, K Højlund, M Andersen… - Diabetes …, 2008 - Am Diabetes Assoc
OBJECTIVE—We investigated the relation between soluble CD36 (sCD36), risk markers of
atherosclerosis and body composition, and glucose and lipid metabolism in polycystic ovary …
atherosclerosis and body composition, and glucose and lipid metabolism in polycystic ovary …
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome
F Giallauria, S Palomba, F Manguso… - Clinical …, 2008 - Wiley Online Library
Objective Heart rate recovery (HRR) is a measure derived from exercise test, defined as the
fall in heart rate during the first minute after maximal exercise. Abnormal HRR is a measure …
fall in heart rate during the first minute after maximal exercise. Abnormal HRR is a measure …
Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome
R Thomann, N Rossinelli, U Keller, BF Tirri… - Gynecological …, 2008 - Taylor & Francis
Background. Polycystic ovary syndrome (PCOS) and gestational diabetes mellitus (GDM)
are both characterized by an increase in insulin resistance. Our goal in the present study …
are both characterized by an increase in insulin resistance. Our goal in the present study …
HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?
PH Kodaman, AJ Duleba - Drugs, 2008 - Springer
Many women of reproductive age are affected by polycystic ovary syndrome (PCOS), a
heterogeneous endocrinopathy characterized by androgen excess, chronic oligo …
heterogeneous endocrinopathy characterized by androgen excess, chronic oligo …
Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome
LOBF Costa, MP dos Santos, M Oliveira… - diabetes research and …, 2008 - Elsevier
OBJECTIVE: To evaluate the presence of premature subclinical atherosclerosis, measured
by examining carotid intima-media thickness (IMT) and to investigate whether the IMT may …
by examining carotid intima-media thickness (IMT) and to investigate whether the IMT may …